This is the first mouse model with a comparable phenotype to human PRPF31-RP patients, providing a new platform to investigate the pathogenetic mechanisms of PRPF31 and to evaluate treatment efficacy in vivo. This evidence concerns the gene PRPF31 and retinitis pigmentosa 1.